Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 6/20 | 1.00 |
| ▸ | DRD2 | P14416 | 5/20 | 1.00 |
| ▸ | DRD3 | P35462 | 5/20 | 1.00 |
| ▸ | HTR7 | P34969 | 4/20 | 1.00 |
| ▸ | HTR1D | P28221 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | HTR1B | P28222 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | ADRA1B | P35368 | 1/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | HTR5A | P47898 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.97 |
| ▸ | LMNA | P02545 | 1/20 | 0.97 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.97 |
| ▸ | DRD4 | P21917 | 3/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 8-Oh-Dpat SCHEMBL29565039 | 1.00 | HTR1A (1.00) | HTR1ADRD2DRD3HTR7HTR1D | |
| 8-Oh-Dpat SCHEMBL1682330 | 1.00 | HTR1A (1.00) | HTR1ADRD2DRD3HTR7HTR1D | |
| 8-Oh-Dpat SCHEMBL1682347 | 1.00 | HTR1A (1.00) | HTR1ADRD2DRD3HTR7HTR1D | |
| 8-Oh-Dpat SCHEMBL29389900 | 1.00 | HTR1A (1.00) | HTR1ADRD2DRD3HTR7HTR1D | |
| 8-Oh-Dpat SCHEMBL1682286 | 0.99 | BLM (1.00) | HTR1ADRD2DRD3HTR7HTR1D | |
| 8-Oh-Dpat SCHEMBL1682320 | 0.99 | BLM (1.00) | HTR1ADRD2DRD3HTR7HTR1D | |
| 8-Oh-Dpat SCHEMBL1682308 | 0.99 | BLM (1.00) | HTR1ADRD2DRD3HTR7HTR1D | |
| SCHEMBL8892193 | 0.95 | HTR1A (1.00) | HTR1ADRD2DRD3HTR7HTR1D | |
| SCHEMBL8891873 | 0.94 | HTR1A (0.90) | HTR1ADRD2DRD3HTR7HTR1D | |
| 8-Oh-Dpat SCHEMBL29420387 | 0.91 | HTR1A (0.82) | HTR1ADRD2DRD3HTR7HTR1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12434068-B2 | Accessing spinal networks to address sexual dysfunction | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-10-07 | — | — | US | claimed |
| EP-4299106-B1 | ACCESSING SPINAL NETWORK TO ENABLE RESPIRATORY FUNCTION | UNIV CALIFORNIA (US) | 2025-09-03 | — | — | EP | claimed |
| EP-4468884-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | Amarin Pharmaceuticals Ireland Limited (IE) | 2024-12-04 | — | — | EP | claimed |
| US-20240374541-A1 | ENGAGING THE CERVICAL SPINAL CORD CIRCUITRY TO RE-ENABLE VOLITIONAL CONTROL OF HAND FUNCTION IN TETRAPLEGIC SUBJECTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-11-14 | — | — | US | claimed |
| US-20240252535-A1 | CELLULAR COMPOSITION FOR TREATMENT OF DISEASES, DISORDERS OR CONDITIONS AND METHOD OF USE | YZTHERAPEUTIC PERFORMANCE LTD. (IL) | 2024-08-01 | — | — | US | claimed |
| EP-4299106-A2 | ACCESSING SPINAL NETWORK TO ENABLE RESPIRATORY FUNCTION | The Regents of The University of California (US) | 2024-01-03 | — | — | EP | claimed |
| WO-2023146984-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2023-08-03 | — | — | WO | claimed |
| EP-4208177-A1 | CELLULAR COMPOSITION FOR TREATMENT OF DISEASES, DISORDERS OR CONDITIONS AND METHOD OF USE | Yztherapeutic Performance Ltd. (IL) | 2023-07-12 | — | — | EP | claimed |
| US-11298533-B2 | Concerted use of noninvasive neuromodulation device with exoskeleton to enable voluntary movement and greater muscle activation when stepping in a chronically paralyzed subject | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-12 | — | — | US | claimed |
| US-11123312-B2 | Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-09-21 | — | — | US | claimed |
| WO-1996001107-A1 | USE OF PHARMACEUTICAL AGENTS FOR RESTORING, ALLEVIATION, OR TREATMENT OF IMMUNODEFICIENCY, INCLUDING THE ALLEVIATION OR TREATMENT OF THE IMMUNE DYSFUNCTION RELATED TO INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUSES (HIV) OR RELATED VIRUSES | HOFMANN BO ARNE (DK) | 1996-01-18 | — | — | WO | claimed |
| WO-1996001106-A1 | USE OF PHARMACEUTICAL AGENTS FOR ALLEVIATION OR TREATMENT OF THE IMMUNE DYSFUNCTION RELATED TO INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUSES (HIV) OR RELATED VIRUSES | HOFMANN BO ARNE (DK) | 1996-01-18 | — | — | WO | claimed |
| EP-0565274-A1 | 5-Ht1A agonists for improving primary memory and/or learning | ELI LILLY AND COMPANY (US) | 1993-10-13 | — | — | EP | claimed |
| EP-0345948-B1 | USE OF 5-HT1A AGONISTS FOR THE MANUFACTURE OF A MEDICAMENT PROTECTING AGAINST ISCHAEMIC DAMAGE | SMITHKLINE BEECHAM PHARMA GmbH (DE) | 1993-08-18 | — | — | EP | claimed |
| US-5189037-A | Mixture of 8-hydroxy-2-(dipropylamino)-1,2,3,4-tetrahydro-naphthalene and 1-(2-pyrimidyl)pyrazine | PFIZER INC (US) | 1993-02-23 | — | — | US | claimed |
| EP-0510837-A2 | Synergistic combinations in the treatment of anxiety | PFIZER INC. (US) | 1992-10-28 | — | — | EP | claimed |
| US-5124346-A | 8-hydroxy-2-(dipropylamino)tetralin and idazoxan | PFIZER INC. (US) | 1992-06-23 | — | — | US | claimed |
| US-5049588-A | 5-hydroxytryptamine antagonist | BEECHAM GROUP P.L.C. (GB) | 1991-09-17 | — | — | US | claimed |
| US-4943428-A | 8-HYDROX-2-(DI-N-PROPYLAMINO)TETRALIN | WRIGHT STATE UNIVERSITY (US) | 1990-07-24 | — | — | US | claimed |
| EP-0345948-A2 | Use of 5-HT1A agonists for the manufacture of a medicament protecting against ischaemic damage | SMITHKLINE BEECHAM PHARMA GmbH (DE) | 1989-12-13 | — | — | EP | claimed |